Despite HK2 overexpression is not caused by HectH9 but likely due to the frequent loss of Pten and p53 in prostate tumors, the co-upregulation of HectH9 and HK2 implicates HectH9’s pathological relevance in glycolytic tumors. This evidence concerns the gene TP53 and prostate neoplasm.